分叉-分叉技术修复腹主动脉瘤合并髂动脉瘤并保留髂内动脉灌注
本研究回顾性分析14例腹主动脉瘤合并髂动脉瘤患者,采用分叉-分叉技术(在髂动脉瘤内放置分叉支架,对侧分支延伸至髂内动脉)修复,技术成功率93%,保留的髂内动脉随访均通畅,1年复合结局(髂内动脉通畅、免于再干预及无临床显著内漏)为92%。
要点
- 分叉-分叉技术修复腹主动脉瘤合并髂动脉瘤技术可行,短期中期结果良好。
- 保留至少一侧髂内动脉灌注可避免盆腔或臀部缺血。
- 1年髂内动脉通畅且免于再干预和临床显著内漏的复合结局为92%。
核心结论
- 分叉-分叉动脉瘤修复术在男性患者中技术可行且安全,短期和中期结果良好。
研究设计与样本
- 回顾性研究,纳入2009年8月至2015年5月共14例腹主动脉瘤合并髂动脉瘤患者。
- 在髂动脉瘤内使用22 mm或24 mm分叉主体装置,对侧分支延伸至髂内动脉。
主要发现
- 技术成功率为93%,成功治疗腹主动脉瘤和髂动脉瘤并保留至少一侧髂内动脉血流。
- 92%的患者采用完全经皮双侧股动脉入路。
- 3例患者初始随访影像发现II型内漏,但均无临床意义。
- 无肠缺血或勃起功能障碍病例。
- 1例患者出现与髂内动脉弹簧圈栓塞同侧的臀部跛行,6个月随访时缓解。
关键数值与推荐
- 技术成功率93%。
- 1年复合结局92%(n=12/13)。
- 保留髂内动脉末次随访通畅率100%(13例)。
临床怎么用
- 对于腹主动脉瘤合并髂动脉瘤患者,可采用分叉-分叉技术使用现成的分叉支架保留髂内动脉灌注。
- 术后需监测髂内动脉瘤增长、支架组件分离及分支血栓形成等并发症。
局限性
- 小样本回顾性研究。
- 仅纳入男性患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Up to 40% of abdominal aortic aneurysms (AAAs) have coexistent iliac artery aneurysms (IAAs). In the past, successful endovascular repair required internal iliac artery (IIA) embolization, which can lead to pelvic or buttock ischemia. This study describes a technique that uses a readily available solution with a minimally altered off-the-shelf bifurcated graft in the IAA to maintain IIA perfusion. METHODS: From August 2009 to May 2015, 14 patients with AAAs and coexisting IAAs underwent repair with a bifurcated-bifurcated approach. A 22-mm or 24-mm bifurcated main body device was used in the IAA with extension of the "contralateral" limb into the IIA. Intraoperative details including operative time, fluoroscopy time, and contrast agent use were recorded. Outcome measures assessed were operative technical success and a composite outcome measure of IIA patency, freedom from reintervention, and clinically significant endoleak at 1 year. RESULTS: Fourteen patients underwent bifurcated-bifurcated repair during the study period. Technical success was achieved in 93% of patients, with successful treatment of the AAA and IAA and preservation of flow to at least one IIA. The procedure was performed with a completely percutaneous bilateral femoral approach in 92% of patients. Three patients had a type II endoleak on initial follow-up imaging, but none were clinically significant. There were no cases of bowel ischemia or erectile dysfunction. One patient had buttock claudication ipsilateral to IIA coil embolization (contralateral to bifurcated iliac repair and preserved IIA) that resolved by 6-month follow-up. Two patients required reinterventions. One patient presented to his first follow-up visit on postoperative day 25 with thrombosis of the right external iliac limb ipsilateral to the bifurcated iliac repair, which was successfully treated with thrombectomy and stenting of the limb. This same patient presented at 83 months with growth of the preserved IIA to 3.9 cm and underwent coil embolization of the aneurysm. Another patient presented for surveillance 44 months after his original repair with component separation of the mating stent and the iliac bifurcated stent grafts. This was treated with a limb extension and endoanchors to fuse the endografts. Of the 13 patients who underwent bifurcated-bifurcated repair, 100% of the preserved IIAs remained patent at last follow-up. The composite outcome measure of IIA patency and freedom from reintervention and clinically significant endoleak at 1 year was 92% (n = 12/13). CONCLUSIONS: In this small retrospective review, bifurcated-bifurcated aneurysm repair of aortoiliac aneurysms with preservation of perfusion to the IIA is technically feasible and safe with good short-term and midterm results in male patients.
引用
- Shin SH, Starnes BW. Bifurcated-bifurcated aneurysm repair is a novel technique to repair infrarenal aortic aneurysms in the setting of iliac aneurysms. J Vasc Surg. 2017. PMID: 28502552. doi:10.1016/j.jvs.2017.02.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。